US83175M2052 - ADR
SMITH & NEPHEW PLC -SPON ADR
NYSE:SNN (5/2/2024, 7:19:59 PM)
Premarket: 24.89 +0.45 (+1.84%)24.44
+0.3 (+1.24%)
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. The company is headquartered in Watford, Hertfordshire and currently employs 19,000 full-time employees. The firm is engaged in developing, manufacturing, marketing and selling medical devices and services. The company is focused on the repair, regeneration and replacement of soft and hard tissue. The company operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
SMITH & NEPHEW PLC -SPON ADR
Building 5, Croxley Park, Hatters Lane
Watford HERTFORDSHIRE WD18 8YE
P: 4401923477100
CEO: Roland Diggelmann
Employees: 19000
Website: https://www.smith-nephew.com/
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN,...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National...
Here you can normally see the latest stock twits on SNN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: